These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21377719)

  • 21. Genetically modified allergens.
    Niederberger V; Valenta R
    Immunol Allergy Clin North Am; 2004 Nov; 24(4):727-38. PubMed ID: 15474868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of sublingual immunotherapy.
    Marcucci F; Duse M; Frati F; Incorvaia C; Marseglia GL; La Rosa M
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):31-3. PubMed ID: 19944008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with recombinant pollen allergens.
    Cromwell O
    Eur Ann Allergy Clin Immunol; 2006 Sep; 38(7):245-6. PubMed ID: 17124784
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
    Pauli G; Larsen TH; Rak S; Horak F; Pastorello E; Valenta R; Purohit A; Arvidsson M; Kavina A; Schroeder JW; Mothes N; Spitzauer S; Montagut A; Galvain S; Melac M; André C; Poulsen LK; Malling HJ
    J Allergy Clin Immunol; 2008 Nov; 122(5):951-60. PubMed ID: 19000581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transition of recombinant allergens from bench to clinical application.
    Cromwell O; Suck R; Kahlert H; Nandy A; Weber B; Fiebig H
    Methods; 2004 Mar; 32(3):300-12. PubMed ID: 14962765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant Allergens in Structural Biology, Diagnosis, and Immunotherapy.
    Tscheppe A; Breiteneder H
    Int Arch Allergy Immunol; 2017; 172(4):187-202. PubMed ID: 28467993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latex allergy: a model for therapy.
    Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2008 Jun; 38(6):898-912. PubMed ID: 18498539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant allergen immunotherapy: clinical evidence of efficacy--a review.
    Makatsori M; Pfaar O; Lleonart R; Calderon MA
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):371-80. PubMed ID: 23740287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory aspects of specific immunotherapy in Europe.
    Kaul S; Englert L; May S; Vieths S
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):594-602. PubMed ID: 20864886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
    Spertini F
    Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [New administration routes for immunotherapy].
    Martorell Aragonés A
    Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From allergen genes to new forms of allergy diagnosis and treatment.
    Vrtala S
    Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Provocation testing with recombinant allergens.
    van Hage-Hamsten M; Pauli G
    Methods; 2004 Mar; 32(3):281-91. PubMed ID: 14962763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trials with recombinant allergens: research studies?
    Pauli G
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
    [No Abstract]   [Full Text] [Related]  

  • 36. B-cell epitopes of allergens determined by recombinant techniques; use for diagnosis and therapy of type I allergy.
    Valenta R; Vrtala S; Laffer S; Steinberger P; Ball T; Ferreira F; Scheiner O; Kraft D
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1994; (87):235-46. PubMed ID: 7532944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of a low immunoglobulin E-binding mutant of the timothy grass pollen major allergen Phl p 5a.
    Wald M; Kahlert H; Weber B; Jankovic M; Keller W; Cromwell O; Nandy A; Fiebig H
    Clin Exp Allergy; 2007 Mar; 37(3):441-50. PubMed ID: 17359394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic engineering of pollen allergens for hayfever immunotherapy.
    Bhalla PL
    Expert Rev Vaccines; 2003 Feb; 2(1):75-84. PubMed ID: 12901599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allergen immunotherapy: where is it now?
    Nelson HS
    J Allergy Clin Immunol; 2007 Apr; 119(4):769-79. PubMed ID: 17337297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind, placebo-controlled evaluation of grass pollen specific immunotherapy with oral drops administered sublingually or supralingually.
    Panzner P; Petrás M; Sýkora T; Lesná I
    Respir Med; 2008 Sep; 102(9):1296-304. PubMed ID: 18585908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.